牛牛AI助理已提取核心訊息
Cardio Diagnostics Holdings, Inc. has submitted a delaying amendment to the U.S. Securities and Exchange Commission (SEC) for its Registration Statement on Form S-3, originally filed on January 26, 2024. The amendment, dated January 29, 2024, is intended to delay the effective date of the registration statement. The company has included the delaying amendment language as required by Rule 473 of the Securities Act of 1933. This language indicates that the registration statement's effective date will be postponed until a further amendment is filed to specify its effectiveness in accordance with section 8(a) of the Securities Act, or until the SEC determines an effective date under the same section. Cardio Diagnostics Holdings has provided contact information for Rupert Russell for any questions or comments from the SEC staff.
Cardio Diagnostics Holdings, Inc. has submitted a delaying amendment to the U.S. Securities and Exchange Commission (SEC) for its Registration Statement on Form S-3, originally filed on January 26, 2024. The amendment, dated January 29, 2024, is intended to delay the effective date of the registration statement. The company has included the delaying amendment language as required by Rule 473 of the Securities Act of 1933. This language indicates that the registration statement's effective date will be postponed until a further amendment is filed to specify its effectiveness in accordance with section 8(a) of the Securities Act, or until the SEC determines an effective date under the same section. Cardio Diagnostics Holdings has provided contact information for Rupert Russell for any questions or comments from the SEC staff.
Cardio Diagnostics Holdings, Inc.已向美國證券交易委員會（SEC）提交了最初於2024年1月26日提交的S-3表格註冊聲明的延遲修正案。該修正案於2024年1月29日生效，旨在推遲註冊聲明的生效日期。該公司已按照1933年《證券法》第473條的要求納入了延遲修正案的措辭。這種措辭表明，註冊聲明的生效日期將推遲到根據《證券法》第8（a）條提交進一步的修正案以說明其有效性之後，或者直到美國證券交易委員會根據同一條款確定生效日期。對於美國證券交易委員會工作人員提出的任何問題或評論，Cardio Diagnostics Holdings已提供了魯珀特·羅素的聯繫信息。
Cardio Diagnostics Holdings, Inc.已向美國證券交易委員會（SEC）提交了最初於2024年1月26日提交的S-3表格註冊聲明的延遲修正案。該修正案於2024年1月29日生效，旨在推遲註冊聲明的生效日期。該公司已按照1933年《證券法》第473條的要求納入了延遲修正案的措辭。這種措辭表明，註冊聲明的生效日期將推遲到根據《證券法》第8（a）條提交進一步的修正案以說明其有效性之後，或者直到美國證券交易委員會根據同一條款確定生效日期。對於美國證券交易委員會工作人員提出的任何問題或評論，Cardio Diagnostics Holdings已提供了魯珀特·羅素的聯繫信息。
有用
沒用